PRICESMART INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data PRICESMART INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2,905	2,997	3,167	3,224	3,329	3,620	4,066	4,412	4,914	5,270
Cost of revenue	2,450	2,520	2,657	2,696	2,775			3,653	4,067	4,356
Gross profit	456	477	510	528	554			759	847	914
General and administrative	64.3	70	88.5	101	107	125	133	135	156	180
Operating income	137	136	126	115	122	158	167	185	221	233
Interest expense	5.89	6.78	5.07	3.94	7.63	7.21	9.61	11	13	11.5
Interest income	1.31	1.81	1.42	1.49	2.03	1.98	2.2	9.87	11	10.1
Other non-operating income	-0.9	1.48	0.19	-1.61	-0.83	-5.6	-3.24	-14.2	-17.6	-24.6
Pre-tax income	131	133	123	111	116	147	156	169	0.1	206
Income tax	42.8	42	48.2	37.6	37.8	49	51.9	60	62.6	58.6
Income from continuing operations	88.7	90.7	74.3
Net income to minority interests			0.08	0.3	0.07	0.2	0.02	0	0
Net income	88.7	90.7	74.3	73.2	78.1	98	105	109	139	148
EBITDA	177	183	179	170	184	223	235	257	304	321
EPS, basic	2.92	2.98	2.44	2.40	2.55	3.18	3.38	3.51	4.57	4.82
EPS, diluted	2.92	2.98	2.44	2.40	2.55	3.18	3.38	3.50	4.57	4.82
Shares, basic (weighted)	29.9	30	30.1	30.2	30.3	30.4	30.6	30.8	30	30.1
Shares, diluted (weighted)	29.9	30	30.1	30.2	30.3	30.4	30.6	30.8	30	30.1
Dividend per share	0.70	0.70	0.70	0.70	0.70	0.70	0.86	0.92	2.16	1.26

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	200	162	93.5	103	299	202	238	240	125	241
Short-term investments			32.3	17	46.5	50.2	11.2	91.1	100	73.2
Receivables	7.46	6.46	8.86	9.87	13.2	12.4	13.4	17.9	18.8	17.4
Inventory	283	311	321	331	310	390	464	471	529	561
Other current assets	22.1	30.1	31.8	31	30.2	39.2	43.9	53.9	57.9	71.1
Total current assets	513	510	488	492	699	697	774	877	832	974
Property, plant and equipment	473	558	594	671	692	730	757	850	936	996
Lease right-of-use assets					120	124	112	114	96.4	113
Goodwill	35.6	35.6	46.3	46.1	45.2	45.1	43.3	43.1	43.2	43.2
Intangible assets			15	12.6	10.2	7.76	0.77
Other non-current assets	49.8	44.7	48.9	45	54.3	57.3	72.9	69	61.6	60.4
Total assets	1,097	1,178	1,216	1,296	1,657	1,706	1,808	2,006	2,023	2,269
Accounts payable	267	272	256	286	373	389	408	453	486	507
Accrued liabilities	19.6	19.2	22.8	25.4	32.9	41.9	44.1	45.4	48.3	52.5
Deferred revenue	20.9	22.1	23	25.3	23.5	26.9	29.2	32.6	38.1	43.1
Short-term debt	14.6	18.4	14.9	25.9	19.4	19.4	33.7	20.2	35.9	38.7
Total current liabilities	368	363	349	407	568	534	579	634	680	726
Long-term debt	73.5	87.9	87.7	63.7	113	110	104	119	94.4	148
Lease liabilities					124	129	118	122	104	122
Other non-current liabilities			5.27	8.69	12.2	10.9	8.44	15.4	14.8	19.8
Total liabilities	459	469	458	498	824	790	817	899	900	1,022
Total debt	88.1	106	103	89.6	132	130	137	140	130	187
Paid-in capital	412	422	433	443	454	465	481	497	515	529
Retained earnings	351	421	474	526	582	659	737	818	890	999
Treasury stock	-32.7	-35.9	-39.1	-38.7	-28.4	-26.1	-31.6	-44	-117	-120
Other comprehensive income	-104	-110	-121	-144	-177	-183	-196	-164	-165	-161
Shareholders' equity	638	709	758	797	832	915	991	1,107	1,123	1,247
Minority interests			0.64	0.93	1.01	0.87
Total equity	638	709	759	798	833	916	991	1,107	1,123	1,247
Total liabilities and equity	1,097	1,178	1,216	1,296	1,657	1,706	1,808	2,006	2,023	2,269
Shares outstanding	30.4	30.4	30.5	30.5	30.7	30.8	30.9	31	30.6	30.7

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	88.7	90.7	74.4	73.5	78.2	98.2	105	109	139	148
Depreciation and amortization	39.8	46.3	52.6	55	61.2	65	67.9	72.7	82.6	88.2
Stock-based compensation	9.12	9.69	10.2	15.1	13.8	18.4	16.8	16.6	17.3	18.8
Deferred income tax	2.88	-2.85	6.96	-2.99	-3.4	-3.85	-3.3	-3.29	-4.08	-4.18
Change in inventory	-15.7	-28	-10.1	-10.2	21.8	-80.2	-74.7	-10.2	-57.3	-32.1
Change in payables	23.2	3.34	-16.5	25.3	90.2	15.5	23.1	43.4	32.5	25
Cash from operations	142	123	119	170	259	127	122	257	208	261
Capital expenditures	-77.7	-135	-98.1	-140	-100	-113	-121	-143	-169	-158
Acquisitions			-23.9
Purchases of investments							-22.5	-139	-184	-79.6
Cash from investing	-78.2	-135	-154	-125	-131	-117	-74.8	-222	-175	-129
Debt issued	14.4	47.7	28.5		57.9	17.6	30.6	38.7	16.5	92.9
Debt repaid	-16.5	-29.4	-32.1	-12.9	-15.2	-20	-22.7	-36	-26.3	-37.4
Stock issued	0.08	0.7	0.27
Share buybacks							-6.26	-12.9	-73.5	-6.71
Dividends paid	-21.3	-21.3	-21.2	-21.7	-21.5	-22	-26.6	-28.5	-66.2	-38.7
Cash from financing	-17.1	-22	-27.8	-32	75.6	-95.1	-12.2	-41.1	-150	14.2
Exchange rate effect	-2.78	-2.84	-6.66	-4.35	-6.08	-3.6	1.03	6.64	2	2.36
Net change in cash	44.1	-37	-68.8	9.32	198	-88.3	35.9	0.83	-116	149
Free cash flow	64.4	-12.3	21.3	30.3	159	14	1.17	115	39	103
Interest paid	4.9	3.77	4.96	3.5	6.88	7.77	9.39	10.6	13.3	11
Income taxes paid	51.2	44.3	52.2	48.3	50.8	58.6	67.1	77.9	90.6	83.7

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to May 31, 2026; growth uses fiscal years. Valuation uses the share price of $174.73 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	17.6%	Gross profit / revenue.
Operating margin	4.5%	Operating income / revenue.
EBITDA margin	6.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	3.9%	Pre-tax income / revenue.
Net margin	2.8%	Net income / revenue.
FCF margin	1.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	4.8%	Cash from operations / revenue.
Effective tax rate	28.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	11.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	6.4%	Net income / average total assets.
Return on invested capital (ROIC)	13.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.5%	Capital expenditures / revenue.
D&A / revenue	1.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	7.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	9.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	9.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	8.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 5y	10.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	5.2%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	11.6%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	13.7%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	5.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	10.9%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	11.8%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	6.5%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	12.3%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	13.6%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	5.5%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	12.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	13.6%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	25.9%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	29.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	0.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	164.2%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	345.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-8.3%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	-41.7%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	13.6%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	12.5%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	11.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	8.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	8.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	12.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	7.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.28x	Current assets / current liabilities.
Quick ratio	0.41x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.39x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.13x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	7.1%	Total debt / total assets.
Liabilities / assets	44.7%	Total liabilities / total assets.
Net debt	-$142.5M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.40x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	16.3x	Operating income / interest expense.
Working capital	$230.7M	Current assets - current liabilities.
Goodwill and intangibles / assets	1.7%	(Goodwill + intangible assets) / total assets.
Tangible book value	$1.35B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	2.26x	Revenue / average total assets.
Fixed asset turnover	5.11x	Revenue / average property, plant and equipment.
Inventory turnover	7.52x	Cost of revenue / average inventory.
Days inventory	49 days	365 x average inventory / cost of revenue.
Receivables turnover	287x	Revenue / average receivables.
Days sales outstanding	1 days	365 x average receivables / revenue.
Days payables	43 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	6 days	Days inventory + days sales outstanding - days payables.
FCF conversion	45.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	73.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.30	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$188.01	Revenue / diluted weighted shares.
FCF per share	$2.44	Free cash flow / diluted weighted shares.
Operating cash flow per share	$9.06	Cash from operations / diluted weighted shares.
Book value per share	$45.12	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$43.72	Tangible book value / shares outstanding.
Cash per share	$10.44	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	13.2%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$5.39B	Share price x shares outstanding.
Enterprise value	$5.25B	Market cap + total debt - cash - short-term investments.
P/E	33.6x	Market cap / net income. Only when net income is positive.
P/S	0.95x	Market cap / revenue.
P/B	3.87x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	4.00x	Market cap / tangible book value, when positive.
P/FCF	73.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	19.7x	Market cap / cash from operations, when positive.
EV/Sales	0.92x	Enterprise value / revenue.
EV/EBIT	20.4x	Enterprise value / operating income, when both are positive.
EV/EBITDA	14.9x	Enterprise value / EBITDA, when both are positive.
EV/FCF	71.2x	Enterprise value / free cash flow, when both are positive.
FCF yield	1.4%	Free cash flow / market cap.
Earnings yield	3.0%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.2%	(Dividends paid + share buybacks) / market cap.
PEG	2.68x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was PRICESMART INC's revenue in fiscal 2025?

PRICESMART INC reported revenue of $5.27B for fiscal 2025, 7.2% higher than the year before.

Was PRICESMART INC profitable in fiscal 2025?

Yes. Net income was $147.9M, a net margin of 2.8%.

How much free cash flow did PRICESMART INC generate in fiscal 2025?

Cash from operations of $261.3M minus capital expenditures of $158.1M left free cash flow of $103.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to PRICESMART INC